ICI+CchemotherapyNSCLC
… a 8.3 month increase in median overall survival when receiving ICI+C versus ICI alone, whereas patients with a low score (∆TRI ≤16, …
1articles mentioning drugs
16drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: ICI+C ×
ICI+C
This drug is selected. Its supporting articles are shown below.